Eton Pharmaceuticals (ETON) Total Liabilities (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Total Liabilities data on file, last reported at $66.0 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 27.59% year-over-year to $66.0 million; the trailing twelve-month figure through Dec 2025 stood at $66.0 million (up 27.59% YoY), and the FY2025 full-year result was $66.0 million, up 27.59% from the prior year.
• Total Liabilities retreated to $66.0 million in Q4 2025, from $81.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $81.4 million in Q3 2025 to a low of $9.2 million in Q2 2021.
• A 5-year average of $26.5 million and a median of $14.4 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities retreated 7.7% in 2021 and soared 323.26% in 2025, its largest moves.
• Tracing ETON's Total Liabilities over 5 years: stood at $9.8 million in 2021, then gained by 21.53% to $12.0 million in 2022, then jumped by 36.07% to $16.3 million in 2023, then jumped by 217.87% to $51.7 million in 2024, then grew by 27.59% to $66.0 million in 2025.
• Business Quant data shows ETON's Total Liabilities at $66.0 million in Q4 2025, $81.4 million in Q3 2025, and $77.7 million in Q2 2025.